Potential curability of newly diagnosed acute promyelocytic leukemia without use of chemotherapy:: the example of liposomal all-trans retinoic acid

被引：21

作者：

Estey, E ^{[1
]}

Koller, C ^{[1
]}

Tsimberidou, AM ^{[1
]}

O'Brien, S ^{[1
]}

Beran, M ^{[1
]}

Cortes, J ^{[1
]}

Tirado-Gomez, M ^{[1
]}

Lopez-Berestein, G ^{[1
]}

Kantarjian, H ^{[1
]}

机构：

[1] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

来源：

BLOOD | 2005年 / 105卷 / 03期

关键词：

D O I：

10.1182/blood-2004-09-3437

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1366 / 1367

页数：2

共 5 条

[1] Implications of potential cure in acute myelogenous leukemia: Development of subsequent cancer and return to work [J].

deLima, M ;

Strom, SS ;

Keating, M ;

Kantarjian, H ;

Pierce, S ;

OBrien, S ;

Freireich, E ;

Estey, E .

BLOOD, 1997, 90 (12) :4719-4724

[2] Treatment of newly-diagnosed acute promyelocytic leukemia with liposomal all-trans retinoic acid [J].

Estey, E ;

Koller, C ;

Cortes, J ;

Reed, P ;

Freireich, E ;

Giles, F ;

Kantarjian, H .

LEUKEMIA & LYMPHOMA, 2001, 42 (03) :309-316

[3] Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia [J].

Estey, EH ;

Giles, FJ ;

Kantarjian, H ;

O'Brien, S ;

Cortes, J ;

Freireich, EJ ;

Lopez-Berestein, G ;

Keating, M .

BLOOD, 1999, 94 (07) :2230-2235

[4]

Estey EH, 2003, BLOOD, V102, p618A

[5]

Sanz MA, 2000, BLOOD, V96, P1247

← 1 →